About Navicare Pharma Private Limited
Data last updated:
Navicare Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 03 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2011PTC216977. Its GSTIN is 27AAECN9258N1ZO (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kunal Navin Saxena and Navin Satyapal Sexena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rusan House 58 – D Govt. Industrial Estate Charkop Kandivali (West), Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2024, the company reported a revenue of ₹62.6 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹10.61 Lakh (net margin -17%) and EBITDA of -₹9.53 Lakh (EBITDA margin -15.2%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.
The company is associated with 1 brand: Navicare.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website navicare.in.
Company details
Contact details
Navicare Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is navicare.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressRusan House 58 – D Govt. Industrial Estate Charkop Kandivali (West), Mumbai, Maharashtra, India – 400067
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Navicare Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Navicare Pharma operates one associated brand: Navicare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Home-based rehabilitation services are delivered to patients in need. | navicare.in |
Business activity
The main business activity of Navicare Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Navicare Pharma Private Limited, buy the company report.
Financials of Navicare Pharma Private Limited
FY 2025 filings availableNavicare Pharma Private Limited reported revenue of ₹62.6 Lakh (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 2% fall in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15.2% | ||||
| Net Profit Margin | -17% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Navicare Pharma Private Limited, buy the company report.
Board of directors of Navicare Pharma Private Limited
Navicare Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kunal Navin Saxena Also directs: Rusan Health Care Private Limited, Rusan Pharma Limited, Euromed International Private Limited and 5 more | Director | 19 Apr 2013 | 13 Years 6 Months | Current |
| Navin Satyapal Sexena Also directs: Rusan Health Care Private Limited, Rusan Pharma Limited, Euromed International Private Limited and 4 more | Director | 03 May 2011 | 15 Years 6 Months | Current |
Auditor
Navicare Pharma Private Limited is audited by GUPTA SAHARIA & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA SAHARIA & CO. | FY 2022 | 103446W |
Shareholding
The shareholding of Navicare Pharma Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Navicare Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Navicare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Navicare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Navicare Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECN9258N1ZO | Maharashtra | Active | 08 May 2018 |
To see the full GST registrations and return filing status of Navicare Pharma Private Limited, buy the company report.
Recent activity
Navicare Pharma Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Archana Navin Saxena ceased to be Director on 20 Apr 2013.
Frequently asked questions
Navicare Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 03 May 2011 (15+ years old) and is registered under CIN U24110MH2011PTC216977.
Navicare Pharma has 2 current directors:
- Kunal Navin Saxena - Director
- Navin Satyapal Sexena - Director
The latest financial statements of Navicare Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Navicare Pharma is 27AAECN9258N1ZO, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Navicare Pharma is U24110MH2011PTC216977. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Navicare Pharma was incorporated on 03 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Archana Navin Saxena ceased to be Director on 20 Apr 2013. Kunal Navin Saxena was appointed as Director on 19 Apr 2013. Navin Satyapal Sexena was appointed as Director on 03 May 2011.
Navicare Pharma can be reached through the website navicare.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Navicare Pharma is at Rusan House 58 – D Govt. Industrial Estate Charkop Kandivali West, Mumbai, Maharashtra, India – 400067.
Navicare Pharma operates in the healthcare industry, in the preventive health services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
